This article is more than 5 years old. Information may no longer be current.

Osseon steerable balloon receives FDA clearance

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Osseon announced recently that its Osseoflex SB 2-mL steerable balloon has received U.S. Food and Drug Administration clearance.

The steerable balloon, which is now available commercially, marks the company’s latest installment to its steerable, articulating, vertebral augmentation product line, according to a company press release.

The Osseoflex is able to navigate within the vertebra to create a central cavity across the sagittal midline. The addition of a smaller, 2-mL balloon size to the product line will accommodate treatment of compression fractures of smaller vertebra in the thoracic and lumbar spine, the release said.

Reference: www.osseon.com.